NRXP
NRx Receives FDA Approval for Preservative-Free Ketamine
NRx received FDA approval for its preservative-free ketamine andase Raywood deal
NRXP news
Latest 3 stories · newest Nov 2, 2026
NRXP
NRxp Pharma's Ketamine ANDA amendment reclassified as minor by FDA
NRx Pharmaceuticals announced the FDA Office of Generic Drugs has reclassified a major amendment to its ketamine ANDA as a minor amendment. This designation revision lowers the regulatory resource requirement and updates the goal date to November 10, 2026.
NRXP
NRx Pharmaceuticals announces underwritten public offering of common stock
NRx Pharmaceuticals announced a proposed underwritten public offering of common stock with BTIG and Lucid Capital Markets as lead bookrunners. The company intends to use net proceeds for working capital and general corporate purposes to support growth.
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same NRXP feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/NRXP/newsSTART FREE